Improve your knowledge about R and deep learning with the courses that Universitat de Barcelona (UB), Bioinformatics Barcelona member (BIB), is offering for this June, July, and September 2021.
News and events
Discover everything you ever wanted to know and beyond about the BIB bioinformatics training and education ecosystem.
The company Sequentia Biotech, BIB MEMBER, has collaborated in the development of a new COVID-19 vaccine. The new vaccine is similar to others already authorized because it stimulates the immune response against the Spike protein that the Coronavirus uses to infect cells.
ALBA SYNCHROTRON, Bioinformatics Barcelona (BIB) member, is offering internships on Bioinformatics for the academic year 21-22 in different branches of the facilities.
Researchers at IRB Barcelona, a BIB member, have discovered that the HMCES enzyme is very effective against lung tumours with a higher number of mutations caused by the APOBEC system (an antiviral defence mechanism).
The BIB's Toolkit on ethics for the bioinformatics "Toolkit para la formación en ética de la bioinformática" is now available on BIB's website.
A total of four CFGS students in Web Application Design - Bioinformatics Profile who do their internships in Dual format in public or public-biomedical research centers can apply for SANEC Program grants.
Sequentia, BIB' Member, launch an RNAseq Grant Programme, in the frame of AIR. The call, open up to 15th April, enhance the participation of Researchers to submit their project to access AIR and analyze their data with the Sequentia RNAseq cloud software.
New BIB's Member: Welcome to Dreamgenics to the Bioinformatics Barcelona (BIB) ecosystem. BIB enlarges its varied ecosystem with a new partner: Dreamgenics, a company that develops its activity in the field of omics technologies and bioinformatics.
The Center for the Integration of Medicine and Innovative Technologies (CIMTI) a BIB collaborator, has opened an Open Call for Innovation aimed at receiving proposals that offer innovative solutions in the health and social fields such as medical devices, in-vitro diagnostics, and eHealth.
The results have been amazing, and we are thankful to all the professionals and patients that have participated.